Cargando…
A pilot study to determine the occurrence of concomitant diseases and drug intake in patients on antituberculosis therapy
INTRODUCTION: Altered pharmacokinetics of antituberculosis (anti-TB) drugs due to interaction with non-TB medications or concomitant diseases may lead to suboptimal plasma levels of the affected drugs and hence contribute to the emergence of drug resistance in mycobacteria. Yet, few studies have inv...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060940/ https://www.ncbi.nlm.nih.gov/pubmed/30090786 http://dx.doi.org/10.4103/jfmpc.jfmpc_103_17 |